Inquirer on MSN3d
US approves 1st fast-acting insulin biosimilar for diabetes
The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls ...
Biocon Biologics, Civica partner to expand Insulin Aspart access in the US
Biocon Biologics' own Insulin Aspart drug product for the US is currently under review by the US Food and Drug Administration ...
Biocon Biologics to supply Insulin Aspart drug substance to Civica for US market
Biocon Biologics partners with Civica to enhance access to Insulin Aspart in the US, no tech transfer involved.
The Punch on MSN3d
NAFDAC alerts Nigerians on circulation of substandard insulin syringes
The National Agency for Food and Drug Administration and Control has raised the alarm over the illegal circulation and ...
CA insulin
Why it matters: More than 3.5 million Californians have diabetes, and insulin is a life-saving part of their disease ...
Trump’s pick to lead FDA tells senators he’d look into food, abortion pill, vaccine advisers
President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...
Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the US
Biocon Biologics has partnered with Civica to improve access to and affordability of insulin aspart in the U.S. Biocon will ...
The Punch on MSN13h
Artificial sweeteners linked to insulin spike, artery damage
The study states that artificial sweeteners, also known as non-nutritive sweeteners, have long been used as a low-calorie ...
California Made a Big Bet on Producing Its Own Insulin, But There’s No ‘Date Certain’ for Delivery
During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...
Philippine Daily Inquirer3d
US approves 1st fast-acting insulin biosimilar for diabetes
The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls the new drug “Merilog,” a biosimilar to the widely-used insulin ...